Belenos Biosciences
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
Key Contacts at Belenos Biosciences
Donnie Mcgrath
Chief Executive Officer
Megan Dow
Chief Operating Officer, Co-Founder
Daniel Franjic
Executive Director, Clinical Development
Jennifer Madonia
Senior Medical Director, Clinical Development
Belenos Biosciences Email Formats
Belenos Biosciences uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@belenosbio.com), used 87.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@belenosbio.com | 87.5% |
{first initial}{last name} | jdoe@belenosbio.com | 12.5% |
About Belenos Biosciences
At Belenos Biosciences Inc., we believe that clinical remission should be the standard—not the exception—for treating chronic inflammatory diseases like COPD, asthma and atopic dermatitis. Our bispecific therapeutics are designed to target proven disease pathways, with the goal of delivering meaningful, lasting outcomes for patients. With a focus on innovation and speed, we are advancing our pipeline with urgency to bring next-generation treatments to those who need them most. An Orbimed company
Belenos Biosciences revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | $48,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Belenos Biosciences has 4 employees across 3 departments.
Departments
Number of employees
Slovenia
Hong Kong
United Kingdom
ItalyFrequently asked questions
4.8
40,000 users
